Orphan designation: humanised IgG2k Fc-modified bispecific monoclonal antibody against CD3 and BCMA Treatment of multiple myeloma, 19/07/2021 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 May 2026 - 11:56

Orphan designation: humanised IgG2k Fc-modified bispecific monoclonal antibody against CD3 and BCMA Treatment of multiple myeloma, 19/07/2021 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-21-2471

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters